Published in Emerg Infect Dis on February 01, 2007
Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis (2009) 1.63
Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLoS One (2011) 1.19
Global research priorities for infections that affect the nervous system. Nature (2015) 1.01
Group B streptococcal carriage, serotype distribution and antibiotic susceptibilities in pregnant women at the time of delivery in a refugee population on the Thai-Myanmar border. BMC Infect Dis (2012) 0.91
Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein. Clin Vaccine Immunol (2008) 0.91
Population structure of human isolates of Streptococcus agalactiae from Dakar and Bangui. J Clin Microbiol (2008) 0.91
The microbial spectrum of neonatal sepsis in Uganda: recovery of culturable bacteria in mother-infant pairs. PLoS One (2013) 0.85
A high burden of late-onset sepsis among newborns admitted to the largest neonatal unit in central Vietnam. J Perinatol (2015) 0.84
Induction and termination of inflammatory signaling in group B streptococcal sepsis. Immunol Rev (2008) 0.84
Burden of bacterial resistance among neonatal infections in low income countries: how convincing is the epidemiological evidence? BMC Infect Dis (2015) 0.84
Breast milk and Group B streptococcal infection: vector of transmission or vehicle for protection? Vaccine (2014) 0.83
Anti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection. Vaccine (2014) 0.82
Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa. BMC Res Notes (2015) 0.81
Isolation and anti-microbial susceptibility pattern of group B Streptococcus among pregnant women attending antenatal clinics in Ayder Referral Hospital and Mekelle Health Center, Mekelle, Northern Ethiopia. BMC Res Notes (2015) 0.80
Susceptibility of bacterial etiological agents to commonly-used antimicrobial agents in children with sepsis at the Tamale Teaching Hospital. BMC Infect Dis (2013) 0.80
Epidemiology and management of group B streptococcal colonization during pregnancy in Africa. Wien Klin Wochenschr (2012) 0.79
Bacteraemia in Malawian neonates and young infants 2002-2007: a retrospective audit. BMJ Open (2012) 0.78
Group B Streptococcus Colonization among Pregnant Women Attending Antenatal Care at Tertiary Hospital in Rural Southwestern Uganda. Int J Microbiol (2016) 0.78
Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya. Nat Microbiol (2016) 0.77
Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance Methodology. PLoS One (2016) 0.77
A three year descriptive study of early onset neonatal sepsis in a refugee population on the Thailand Myanmar border. BMC Infect Dis (2013) 0.77
'Tweaking' the model for understanding and preventing maternal and neonatal morbidity and mortality in Low Income Countries: "inserting new ideas into a timeless wine skin". BMC Pregnancy Childbirth (2016) 0.75
Antigenic distribution of Streptococcus agalactiae isolates from pregnant women at Garankuwa hospital - South Africa. Germs (2015) 0.75
Rational development of guidelines for management of neonatal sepsis in developing countries. Curr Opin Infect Dis (2015) 0.75
Comparison Between Pathogen Associated Laboratory and Clinical Parameters in Early-Onset Sepsis of the Newborn. Open Microbiol J (2016) 0.75
Challenges in reducing group B Streptococcus disease in African settings. Arch Dis Child (2016) 0.75
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries. F1000Res (2016) 0.75
Group B Streptococcus among pregnant women and newborns in Mirzapur, Bangladesh: Colonization, vertical transmission and serotype distribution. J Clin Microbiol (2017) 0.75
Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med (2005) 13.27
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med (2000) 6.58
Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr (1973) 6.29
Group B streptococcus. Lancet (1999) 3.41
Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J Infect Dis (1998) 3.18
Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi. AIDS (2006) 2.34
Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin Infect Dis (2000) 2.10
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest (1996) 2.05
Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ (1997) 2.03
Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis (2004) 1.91
BSAC standardized disc susceptibility testing method (version 4). J Antimicrob Chemother (2005) 1.86
Causes and outcome of young infant admissions to a Kenyan district hospital. Arch Dis Child (2003) 1.81
Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet (2004) 1.77
Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections. Pediatr Infect Dis J (1999) 1.52
Carriage of group B Streptococci in pregnant Gambian mothers and their infants. J Infect Dis (1994) 1.43
Aetiology of neonatal sepsis in Blantyre, Malawi: 1996-2001. Ann Trop Paediatr (2005) 1.41
Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J (1998) 1.39
High burden of invasive Streptococcus agalactiae disease in South African infants. Ann Trop Paediatr (2003) 1.34
Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study. Antimicrob Agents Chemother (2001) 1.34
Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine (2003) 1.31
Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis (1999) 1.30
Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative. Vaccine (2003) 1.24
Neonatal & maternal group B streptococcal infections: a comprehensive review. Indian J Med Res (2004) 1.22
Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001. Clin Microbiol Infect (2004) 1.20
Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe. J Med Microbiol (2002) 1.19
Neonatal bacterial meningitis at the newborn unit of Kenyatta National Hospital. East Afr Med J (2003) 1.16
Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14. Infect Immun (2002) 1.08
Neonatal group B streptococcal disease in Finland: a ten-year nationwide study. Pediatr Infect Dis J (1999) 1.05
Neonatal septicaemia in Harare Hospital: aetiology and risk factors. The Puerperal Sepsis Study Group. Cent Afr J Med (1990) 1.05
Serotypes and clinical manifestations of group B streptococcal infections in western Sweden. Clin Microbiol Infect (2000) 1.04
Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes. Obstet Gynecol (2006) 1.03
Invasive group B streptococcal infections in Finland: a population-based study. Emerg Infect Dis (2003) 1.03
Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis (2003) 1.02
Pneumococcal vaccination in HIV-1-infected adults in Uganda: humoral response and two vaccine failures. AIDS (1998) 0.97
Is prophylaxis of early-onset group B streptococcal disease appropriate for South Africa? S Afr Med J (2001) 0.96
Conclusions from the WHO multicenter study of serious infections in young infants. The WHO Young Infants Study Group. Pediatr Infect Dis J (1999) 0.95
Invasive group B streptococcal infections in Sweden: incidence, predisposing factors and prognosis. Int J Infect Dis (2003) 0.90
Epidemiology of group B streptococcal carriage among pregnant women and their neonates: an African experience. Trop Geogr Med (1983) 0.87
Susceptibility of Zimbabwean Streptococcus agalactiae (group B Streptococcus; GBS) isolates to four different antibiotics. Cent Afr J Med (2003) 0.87
Easing the burden: characterizing the disease burden of neonatal group B streptococcal disease to motivate prevention. Clin Infect Dis (2004) 0.85
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA (2004) 6.74
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med (2007) 4.56
Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis (2008) 3.89
The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med (2011) 3.25
Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. J Infect Dis (2007) 3.19
Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis (2002) 2.54
A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV. J Acquir Immune Defic Syndr (2005) 2.47
Population-level reduction in adult mortality after extension of free anti-retroviral therapy provision into rural areas in northern Malawi. PLoS One (2010) 2.36
The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J Clin Invest (2008) 2.35
Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. Lancet Infect Dis (2011) 2.32
Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi. J Infect Dis (2006) 2.22
Meta-analysis of six-month memantine trials in Alzheimer's disease. Alzheimers Dement (2007) 2.18
HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS (2004) 2.12
Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med (2014) 2.12
Underestimation of HIV prevalence in surveys when some people already know their status, and ways to reduce the bias. AIDS (2013) 2.06
Pneumonia in severely malnourished children in developing countries - mortality risk, aetiology and validity of WHO clinical signs: a systematic review. Trop Med Int Health (2009) 1.97
Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med (2013) 1.91
Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries. Lancet Infect Dis (2007) 1.85
Profile: the Karonga Health and Demographic Surveillance System. Int J Epidemiol (2012) 1.85
High accuracy of home-based community rapid HIV testing in rural Malawi. J Acquir Immune Defic Syndr (2010) 1.73
Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet (2010) 1.69
Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc Natl Acad Sci U S A (2010) 1.68
Assessing the safety of stem cell therapeutics. Cell Stem Cell (2011) 1.60
Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial. Am J Geriatr Psychiatry (2006) 1.57
Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology (2006) 1.47
Perineal approach for artificial urinary sphincter implantation appears to control male stress incontinence better than the transscrotal approach. J Urol (2008) 1.44
Measuring concurrency: an empirical study of different methods in a large population-based survey and evaluation of the UNAIDS guidelines. AIDS (2012) 1.40
Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. PLoS One (2011) 1.39
Age at menarche, schooling, and sexual debut in northern Malawi. PLoS One (2010) 1.39
Combining qualitative and quantitative evidence to determine factors leading to late presentation for antiretroviral therapy in Malawi. PLoS One (2011) 1.38
The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level--a comparative analysis of data from four settings in Southern and East Africa. Trop Med Int Health (2012) 1.38
Adult mortality and probable cause of death in rural northern Malawi in the era of HIV treatment. Trop Med Int Health (2012) 1.38
Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis (2012) 1.38
Molecular detection of mixed infections of Mycobacterium tuberculosis strains in sputum samples from patients in Karonga District, Malawi. J Clin Microbiol (2010) 1.33
Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda. J Acquir Immune Defic Syndr (2006) 1.29
Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence. Pediatr Infect Dis J (2003) 1.28
Closing the policy-practice gap in the management of child contacts of tuberculosis cases in developing countries. PLoS Med (2011) 1.26
Interactions between HIV and malaria in non-pregnant adults: evidence and implications. AIDS (2006) 1.20
Progress and challenges in childhood tuberculosis. Lancet Infect Dis (2013) 1.16
Childhood tuberculosis: progress requires an advocacy strategy now. Eur Respir J (2012) 1.11
Identification and characterization of ceftriaxone resistance and extended-spectrum beta-lactamases in Malawian bacteraemic Enterobacteriaceae. J Antimicrob Chemother (2006) 1.11
Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury. Hepatology (2013) 1.10
Assessing the validity of sexual behaviour reports in a whole population survey in rural Malawi. PLoS One (2011) 1.10
Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine. J Infect Dis (2005) 1.10
The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting. AIDS (2012) 1.10
Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Trans R Soc Trop Med Hyg (2004) 1.09
Group B Streptococcus and HIV infection in pregnant women, Malawi, 2008-2010. Emerg Infect Dis (2011) 1.08
Screening and preventive therapy for tuberculosis. Clin Chest Med (2009) 1.08
Toxicity of first-line drugs for treatment of tuberculosis in children: review. Trop Med Int Health (2009) 1.08
Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis (2009) 1.07
Observational cohort study of HIV-infected African children. Pediatr Infect Dis J (2006) 1.07
PCR improves diagnostic yield from lung aspiration in Malawian children with radiologically confirmed pneumonia. PLoS One (2011) 1.05
Fertility intentions and use of contraception among monogamous couples in northern Malawi in the context of HIV testing: a cross-sectional analysis. PLoS One (2012) 1.04
Pneumocystis pneumonia in HIV-positive adults, Malawi. Emerg Infect Dis (2007) 1.04
23-Valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort. AIDS (2004) 1.03
Genetic characterisation of Malawian pneumococci prior to the roll-out of the PCV13 vaccine using a high-throughput whole genome sequencing approach. PLoS One (2012) 1.03
Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type b vaccination, 2000-2012. Clin Infect Dis (2014) 1.02
Monitoring the impact of decentralised chronic care services on patient travel time in rural Africa--methods and results in Northern Malawi. Int J Health Geogr (2012) 1.02
High mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from Malawi. PLoS One (2013) 0.99
Domestic smoke exposure is associated with alveolar macrophage particulate load. Trop Med Int Health (2009) 0.99
Lung fluid immunoglobulin from HIV-infected subjects has impaired opsonic function against pneumococci. Clin Infect Dis (2007) 0.98
Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children. Clin Vaccine Immunol (2013) 0.96
Changes in Mycobacterium tuberculosis genotype families over 20 years in a population-based study in Northern Malawi. PLoS One (2010) 0.96
Control of (multi)drug resistance and tuberculosis incidence over 23 years in the context of a well-supported tuberculosis programme in rural Malawi. PLoS One (2013) 0.96
Blood culture collection technique and pneumococcal surveillance in Malawi during the four year period 2003-2006: an observational study. BMC Infect Dis (2008) 0.95
HIV and the risk of tuberculosis due to recent transmission over 12 years in Karonga District, Malawi. Trans R Soc Trop Med Hyg (2009) 0.95
Characterizing the emergence and persistence of drug resistant mutations in HIV-1 subtype C infections using 454 ultra deep pyrosequencing. BMC Infect Dis (2013) 0.95
Memantine for the treatment of Alzheimer's disease: tolerability and safety data from clinical trials. Drug Saf (2008) 0.92
Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease. Alzheimers Dement (2011) 0.92
Pneumococcal conjugate vaccine is immunogenic in lung fluid of HIV-infected and immunocompetent adults. J Allergy Clin Immunol (2007) 0.92
Eosinophilia and progression to active tuberculosis in HIV-1-infected Ugandans. Trans R Soc Trop Med Hyg (2004) 0.91
A pilot evaluation of the safety, tolerability, pharmacokinetics, and effectiveness of memantine in pediatric patients with attention-deficit/hyperactivity disorder combined type. J Child Adolesc Psychopharmacol (2007) 0.91
Drug resistance mutations in drug-naive HIV type 1 subtype C-infected individuals from rural Malawi. AIDS Res Hum Retroviruses (2010) 0.91
Impact of HIV on standard case management for severe pneumonia in children. Expert Rev Respir Med (2010) 0.90
Malaria treatment efficacy among people living with HIV: the role of host and parasite factors. Am J Trop Med Hyg (2007) 0.90
Contact investigation of children exposed to tuberculosis in South East Asia: a systematic review. J Trop Med (2011) 0.89
Invasive salmonellosis in Malawi. J Infect Dev Ctries (2008) 0.89
Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans. Clin Diagn Lab Immunol (2005) 0.88
Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis. J Pharmacol Exp Ther (2012) 0.87
Preventive therapy in children exposed to Mycobacterium tuberculosis: problems and solutions. Trop Med Int Health (2012) 0.87
Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses. Vaccine (2008) 0.87
Lobar pneumonia caused by nontyphoidal Salmonella in a Malawian child. Pediatr Infect Dis J (2006) 0.86
Morbidity and mortality in hospitalised neonates in central Vietnam. Acta Paediatr (2015) 0.85
Reduced interleukin-8 response to Streptococcus pneumoniae by alveolar macrophages from adults with HIV/AIDS. AIDS (2005) 0.85
Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease. Dement Geriatr Cogn Disord (2009) 0.84
A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease. J Infect Dis (2006) 0.84
A CD45 polymorphism associated with abnormal splicing is absent in African populations. Immunogenetics (2002) 0.82
Rapid molecular detection of tuberculosis. N Engl J Med (2011) 0.82
Maternal HIV status associated with under-five mortality in rural Northern Malawi: a prospective cohort study. J Acquir Immune Defic Syndr (2015) 0.82
In silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteers. Genome Med (2012) 0.81
AIDS patients have increased surfactant protein D but normal mannose binding lectin levels in lung fluid. Respir Res (2007) 0.81
Impact of study design and patient population on outcomes from cholinesterase inhibitor trials. Am J Geriatr Psychiatry (2003) 0.80
HIV in Africa (Communication arising): chemokine-receptor genes and AIDS risk. Nature (2002) 0.80
Characterising B cell numbers and memory B cells in HIV infected and uninfected Malawian adults. BMC Infect Dis (2010) 0.80
Lactate as a predictor of mortality in Malawian children with WHO-defined pneumonia. Arch Dis Child (2012) 0.80
Memantine hydrochloride: pharmacological and clinical profile. Drugs Today (Barc) (2004) 0.79
CD45 variant alleles: possibly increased frequency of a novel exon 4 CD45 polymorphism in HIV seropositive Ugandans. Immunogenetics (2004) 0.78